16950
A subcutaneous formulation of trastuzumab , containing recombinant human hyaluronidase to overcome subcutaneous absorption barriers , would reduce the administration duration and remove the need to establish intravenous access , thus improving the overall convenience of trastuzumab administration .
 None
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Chemical 
Text: {0} 
Answer:
 None